Literature DB >> 8223657

Catalytic mechanism of 3-deoxy-D-manno-2-octulosonate-8-phosphate synthase. The use of synthetic analogues to probe the structure of the putative reaction intermediate.

T Baasov1, S Sheffer-Dee-Noor, A Kohen, A Jakob, V Belakhov.   

Abstract

The proposed mechanistic pathway for the reaction catalyzed by 3-deoxy-D-manno-2-octulosonate-8-phosphate (Kdo8P) synthase was examined in terms of the structure of the putative bisphosphate intermediate. Two 2-deoxy analogues of the product Kdo8P, having been structurally prohibited from undergoing the ring-opening and possessing the stereochemistry of either the alpha-pyranase (compound 1) or the beta-pyranose form (compound 2) of the product, were synthesized and probed as inhibitors for the synthase. It was found that both analogues bind to the enzyme and are competitive inhibitors with respect to phosphoenolpyruvate binding, having Ki values of 470 microM and 303 microM, respectively. Comparison of this data to the Ki value of the tautomeric mixture of the product Kdo8P (Ki = 590 microM) suggests that both the alpha- and the beta-pyranose anomers (65.8% and 3.1%, respectively at neutral pH) bind to the enzyme with a slight (1.13 kJ/mol) preference for the beta-anomer, and that the C2 hydroxyl does not contribute to the binding. This uncertain stereochemical preference exhibited by the enzyme for the stereoisomers at the anomeric carbon suggests that the carboxylate binding site of the product is indistinct, while the hydroxyl and carboxylate binding sites may be interchangeable. More importantly, however, the isosteric phosphonate analogue 2,6-anhydro-3-deoxy-2 beta-phosphonylmethyl-8-phosphate-D-glycero-D-talo-octonate (3), which mimics the topological and electrostatic properties of the proposed cyclic intermediate, was found to be the most potent inhibitor of the enzyme with a Ki value of 5 microM. Two hitherto unrecognized aspects of the mechanism of the synthase were identified. First, the results showing that the cyclic analogues 1, 2 and 3 are inhibitors of the enzyme whereas the previously reported acyclic analogue, which contains no carbonyl group at C2 and may thus resemble the open-chain form of Kdo8P, is not an inhibitor, suggest that the pyranose form and not the open-chain acyclic form of the putative bisphosphate intermediate is handled by the enzyme. Second, since the overall stereochemical course of the transformation mediated by the synthase has been shown to involve si face addition of phosphoenolpyruvate to the re face of the carbonyl of arabinose 5-phosphate, the present observation involving analogue 3 suggest that the bisphosphate intermediate formed during the initial steps of synthesis may have the pyranose structure with the anomeric phosphate located in the beta-configuration.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8223657     DOI: 10.1111/j.1432-1033.1993.tb18330.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  5 in total

1.  The catalytic and conformational cycle of Aquifex aeolicus KDO8P synthase: role of the L7 loop.

Authors:  Xingjue Xu; Fathima Kona; Jian Wang; Jinshuang Lu; Timothy Stemmler; Domenico L Gatti
Journal:  Biochemistry       Date:  2005-09-20       Impact factor: 3.162

2.  Functional and biochemical characterization of a recombinant Arabidopsis thaliana 3-deoxy-D-manno-octulosonate 8-phosphate synthase.

Authors:  Jing Wu; Mayur A Patel; Appavu K Sundaram; Ronald W Woodard
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

3.  Characterization of N-acetylneuraminic acid synthase isoenzyme 1 from Campylobacter jejuni.

Authors:  Appavu K Sundaram; Lee Pitts; Kamilah Muhammad; Jing Wu; Michael Betenbaugh; Ronald W Woodard; Willie F Vann
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

4.  Cloning, expression, and biochemical characterization of 3-deoxy-D-manno-2-octulosonate-8-phosphate (KDO8P) synthase from the hyperthermophilic bacterium Aquifex pyrophilus.

Authors:  Smadar Shulami; Orit Yaniv; Emilia Rabkin; Yuval Shoham; Timor Baasov
Journal:  Extremophiles       Date:  2003-08-29       Impact factor: 2.395

Review 5.  Antibiotics and bacterial resistance in the 21st century.

Authors:  Richard J Fair; Yitzhak Tor
Journal:  Perspect Medicin Chem       Date:  2014-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.